Financial Year |
March 31 2023 |
Monetary Funds |
175,939,209.55 |
Held-for-trading Financial Assets |
171,437,922.50 |
Notes Receivable |
-- |
Accounts Receivable |
107,708,274.45 |
Advances to Suppliers |
15,972,071.75 |
Other Receivables |
45,058,162.74 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
343,371.54 |
Dividend Receivable |
-- |
Inventories |
4,731,126.86 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
3,176,183.70 |
Total Current Assets |
524,022,951.55 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
5,427,383.01 |
Fixed Assetes |
251,320,251.58 |
Under-construction Projects |
101,893,708.70 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
186,308,540.96 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
1,928,534.02 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
548,100,335.01 |
Total Assets |
1,072,123,286.56 |
Short-Term Loans |
123,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
48,816,540.23 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
2,296,797.49 |
Taxes Payable |
1,416,775.08 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
45,523,245.79 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
865,694.27 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
229,790,898.40 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
856,818.83 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
7,210,872.90 |
Total Liabilities |
237,001,771.30 |
Paid-In Capital(Or Share Stock) |
312,452,427.00 |
Capital Surplus |
381,751,560.81 |
Surplus Reserve |
39,469,294.79 |
LESS:Treasury Stock |
10,004,829.52 |
Undistributed Profits |
111,453,062.18 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
835,121,515.26 |
Owner's Equity(Stockholder's Equity) |
835,121,515.26 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,072,123,286.56 |